Clinical Trial Update: Multicenter, Safety Study Of Maraviroc [Phase 3]

View source ↗

Summary

A multicenter Phase 3 safety study of maraviroc in HIV/AIDS patients has completed and its results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Maraviroc (Selzentry) (maraviroc)

Snippet

Sponsor: ViiV Healthcare | Conditions: Acquired Immunodeficiency Syndrome, HIV Infection | Phase 3 | Status: COMPLETED | Results posted: 2011-08-08